Utah legislation · 2026 General Session
Utah HCR10: Concurrent Resolution Directing PEHP Regarding Hormone Replacement Therapy
Status: Signed into law, March 25, 2026
This resolution directs the Public Employees' Benefit and Insurance Program to provide hormone replacement therapy for menopausal symptoms.
What the bill says
From the enrolled text, March 12, 2026:
0 Concurrent Resolution Directing PEHP Regarding Hormone Replacement Therapy 2026 GENERAL SESSION STATE OF UTAH Chief Sponsor: Karianne Lisonbee Senate Sponsor: Heidi Balderree LONG TITLE General Description: This resolution directs the Public Employees' Benefit and Insurance Program to provide hormone replacement therapy for menopausal symptoms. Highlighted Provisions: This resolution: - recognizes that hormone replacement therapy is a safe and effective treatment for menopausal symptoms; and - directs the Public Employees' Benefit and Insurance Program to provide hormone replacement therapy for menopausal symptoms. Money Appropriated in this Bill: None Other Special Clauses: None Be it resolved by the Legislature of the state of Utah, the Governor concurring therein: WHEREAS, in accordance with Section 49-20-201 , the state participates in the Public Employees' Benefit and Insurance Program (PEHP); WHEREAS, menopause is a natural phase of aging when a woman has gone 12 consecutive months without a menstrual period due to a decline in reproductive hormones; WHEREAS, menopause can cause a variety of symptoms including irregular periods, hot flashes, night sweats, vaginal dryness, urinary urgency, difficulty sleeping, emotional changes, dry skin, worsening premenstrual syndrome, and breast tenderness; WHEREAS, many menopausal women face barriers accessing effective treatment due to a range of factors including healthcare provider knowledge gaps, stigma, and lack of readily available menopause specialists; WHEREAS, recent studies have shown that hormone replacement …
Sponsors
- Karianne Lisonbee (R, 14) · primary sponsor
- Heidi Balderree (R, 22)
Latest actions
- : Governor Signed
- : House/ to Governor
- : House/ received enrolled bill from Printing
- : House/ enrolled bill to Printing
- : Enrolled Bill Returned to House or Senate
- : Draft of Enrolled Bill Prepared
- : Bill Received from House for Enrolling
- : House/ signed by Speaker/ sent for enrolling
- : House/ received from Senate
- : Senate/ to House
Votes
- Senate/ passed 3rd reading (March 6, 2026): 23 yea, 0 nay, passed
- House/ concurs with Senate amendment (March 6, 2026): 66 yea, 1 nay, passed
- Senate Comm - Favorable Recommendation (March 2, 2026): 5 yea, 0 nay, passed
- Senate Comm - Consent Calendar Recommendation (March 2, 2026): 5 yea, 0 nay, passed
- Senate Comm - Amendment Recommendation (March 2, 2026): 5 yea, 0 nay, passed
- House/ passed 3rd reading (February 23, 2026): 67 yea, 1 nay, passed
Subjects: Health Insurance, Health and Human Services, Public Employees' Health Program
Common questions
- What is HCR10?
- HCR10 is a bill in the Utah Legislature (2026 General Session): Concurrent Resolution Directing PEHP Regarding Hormone Replacement Therapy.
- What does HCR10 do?
- This resolution directs the Public Employees' Benefit and Insurance Program to provide hormone replacement therapy for menopausal symptoms.
- What is the status of HCR10?
- Signed into law as of March 25, 2026. Latest action: Governor Signed (March 25, 2026).
- Who sponsored HCR10?
- Karianne Lisonbee (R, 14), with 1 co-sponsor.
- Where is the official record for HCR10?
- On the Utah Legislature website: https://le.utah.gov/~2026/bills/static/HCR010.html
Source: official Utah record. Tracked by Delilah, AI for legislation across all 50 states and Congress.